Biomarkers of Exposure and Effect in Standardized Research E-cigarette (SREC) Users
Phase 1
Recruiting
- Conditions
- Smoking, Cigarette
- Interventions
- Drug: Standardized Research E-cigarette (SREC)
- First Posted Date
- 2019-07-01
- Last Posted Date
- 2024-08-14
- Lead Sponsor
- Masonic Cancer Center, University of Minnesota
- Target Recruit Count
- 125
- Registration Number
- NCT04003805
- Locations
- 🇺🇸
University of Minnesota, Masonic Cancer Center, Minneapolis, Minnesota, United States
Nornicotine in Smokeless Tobacco as a Precursor for Carcinogen Exposure
Phase 1
Suspended
- Conditions
- Smokeless Tobacco
- Interventions
- Drug: Herbal Snuff (Smokeless Tobacco)
- First Posted Date
- 2019-06-26
- Last Posted Date
- 2025-04-16
- Lead Sponsor
- Masonic Cancer Center, University of Minnesota
- Target Recruit Count
- 55
- Registration Number
- NCT03998735
- Locations
- 🇺🇸
Masonic Cancer Center, Minneapolis, Minnesota, United States
Assessment of Complete Pathologic Response After Neoadjuvant Chemotherapy for Breast Cancer
Completed
- Conditions
- HER2-positive Breast CancerTriple Negative Breast CancerTN ER-/PR-/HER2- Breast CancerERany/PRany/HER2+ Breast Cancer
- First Posted Date
- 2019-06-11
- Last Posted Date
- 2024-12-27
- Lead Sponsor
- Masonic Cancer Center, University of Minnesota
- Target Recruit Count
- 8
- Registration Number
- NCT03981705
- Locations
- 🇺🇸
University of Minnesota Masonic Cancer Center, Minneapolis, Minnesota, United States
Clinical Trial of Two Study Drinks in Detoxification of Environmental Toxicants and Carcinogens
Phase 2
Completed
- Conditions
- Healthy
- Interventions
- Dietary Supplement: Freeze dried PowderDietary Supplement: Placebo Preparation
- First Posted Date
- 2019-06-06
- Last Posted Date
- 2024-12-03
- Lead Sponsor
- Masonic Cancer Center, University of Minnesota
- Target Recruit Count
- 305
- Registration Number
- NCT03978117
- Locations
- 🇺🇸
University of Minnesota, Minneapolis, Minnesota, United States
BAriaTric Surgery After Breast Cancer Treatment (BATS)
Not Applicable
Not yet recruiting
- Conditions
- ObesityEarly-stage Breast Cancer
- Interventions
- Procedure: Bariatric Surgery with Sleeve GastrectomyBehavioral: Lifestyle Intervention
- First Posted Date
- 2019-05-10
- Last Posted Date
- 2025-02-04
- Lead Sponsor
- Masonic Cancer Center, University of Minnesota
- Target Recruit Count
- 40
- Registration Number
- NCT03946423
CASCARA: Castration Sensitive Carboplatin, Cabazitaxel and Abiraterone
Phase 2
Active, not recruiting
- Conditions
- Prostate Cancer
- Interventions
- First Posted Date
- 2019-05-02
- Last Posted Date
- 2024-02-28
- Lead Sponsor
- Masonic Cancer Center, University of Minnesota
- Target Recruit Count
- 22
- Registration Number
- NCT03934840
- Locations
- 🇺🇸
Thomas Jeferson University, Philadelphia, Pennsylvania, United States
🇺🇸Masonic Cancer Center at University of Minnesota, Minneapolis, Minnesota, United States
🇺🇸University of Chicago, Chicago, Illinois, United States
Radiation and Combination Immunotherapy for Melanoma
Phase 2
Completed
- Conditions
- Metastatic Melanoma
- First Posted Date
- 2019-02-22
- Last Posted Date
- 2024-01-17
- Lead Sponsor
- Masonic Cancer Center, University of Minnesota
- Target Recruit Count
- 4
- Registration Number
- NCT03850691
- Locations
- 🇺🇸
University of Minnesota Masonic Cancer Center, Burnsville, Minnesota, United States
Single Patient Use of Selinexor and Dexamethasone for a Patient With Multiple Myeloma
- Conditions
- Multiple Myeloma
- First Posted Date
- 2019-02-22
- Last Posted Date
- 2019-02-22
- Lead Sponsor
- Masonic Cancer Center, University of Minnesota
- Registration Number
- NCT03850704
Adrenoleukodystrophy National Registry Study
Recruiting
- Conditions
- ALD (Adrenoleukodystrophy)AdrenoleukodystrophyCerebral Adrenoleukodystrophy
- Interventions
- Other: Medical Record AbstractionOther: Biospecimen Sample Collection
- First Posted Date
- 2018-12-31
- Last Posted Date
- 2025-05-08
- Lead Sponsor
- Masonic Cancer Center, University of Minnesota
- Target Recruit Count
- 1000
- Registration Number
- NCT03789721
- Locations
- 🇺🇸
Masonic Cancer Center at University of Minnesota, Minneapolis, Minnesota, United States
Microbiota Changes in Acute Myeloid Leukemia Patients Undergoing Intensive Chemotherapy
Completed
- Conditions
- Acute Myeloid Leukemia
- First Posted Date
- 2018-11-02
- Last Posted Date
- 2023-11-03
- Lead Sponsor
- Masonic Cancer Center, University of Minnesota
- Target Recruit Count
- 54
- Registration Number
- NCT03728699
- Locations
- 🇺🇸
Masonic Cancer Center at University of Minnesota, Minneapolis, Minnesota, United States
© Copyright 2025. All Rights Reserved by MedPath